X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (75144) 75144
Publication (6948) 6948
Newspaper Article (4574) 4574
Government Document (2761) 2761
Newsletter (955) 955
Magazine Article (690) 690
Book Review (548) 548
Book Chapter (439) 439
Dissertation (393) 393
Book / eBook (139) 139
Trade Publication Article (108) 108
Reference (88) 88
Transcript (88) 88
Web Resource (85) 85
Conference Proceeding (72) 72
Patent (69) 69
Report (34) 34
Paper (23) 23
Data Set (22) 22
Presentation (4) 4
Streaming Video (3) 3
Journal / eJournal (2) 2
Photograph (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (45184) 45184
humans (44293) 44293
male (30282) 30282
female (27146) 27146
mass spectrometry (21398) 21398
animals (19840) 19840
adult (16875) 16875
body mass index (15375) 15375
middle aged (15081) 15081
pharmacology & pharmacy (11602) 11602
chemistry, analytical (10898) 10898
analysis (10717) 10717
aged (9373) 9373
research (9242) 9242
rats (8775) 8775
biochemical research methods (7358) 7358
metabolites (7110) 7110
liquid chromatography (7059) 7059
pharmacokinetics (6710) 6710
risk factors (6707) 6707
obesity (6507) 6507
metabolism (6502) 6502
adolescent (6441) 6441
chromatography (6017) 6017
health aspects (5959) 5959
drugs (5942) 5942
medicine (5908) 5908
endocrinology & metabolism (5779) 5779
mass-spectrometry (5719) 5719
reproducibility of results (5560) 5560
mice (5447) 5447
young adult (5394) 5394
studies (4959) 4959
methods (4695) 4695
biochemistry & molecular biology (4661) 4661
proteins (4565) 4565
tandem mass spectrometry - methods (4526) 4526
cancer (4490) 4490
women (4426) 4426
tandem mass spectrometry (4412) 4412
mass spectroscopy (4354) 4354
chromatography, high pressure liquid (4284) 4284
research article (4206) 4206
diabetes (4103) 4103
care and treatment (4099) 4099
administration, oral (3990) 3990
children (3981) 3981
physiological aspects (3850) 3850
scientific imaging (3843) 3843
toxicology (3813) 3813
rats, sprague-dawley (3765) 3765
urine (3722) 3722
treatment outcome (3719) 3719
plasma (3686) 3686
sensitivity and specificity (3640) 3640
chromatography, high pressure liquid - methods (3619) 3619
patients (3597) 3597
child (3596) 3596
risk (3585) 3585
nutrition & dietetics (3566) 3566
multidisciplinary sciences (3538) 3538
usage (3532) 3532
time factors (3531) 3531
public health (3452) 3452
dose-response relationship, drug (3440) 3440
chemistry (3418) 3418
mass media (3400) 3400
medical research (3385) 3385
prevalence (3374) 3374
gas chromatography-mass spectrometry (3285) 3285
tandem mass-spectrometry (3266) 3266
medicine & public health (3264) 3264
chromatography, liquid (3258) 3258
identification (3245) 3245
disease (3206) 3206
chromatography, liquid - methods (3203) 3203
body-mass index (3161) 3161
diagnosis (3083) 3083
mortality (2994) 2994
mass (2879) 2879
science (2872) 2872
aged, 80 and over (2863) 2863
pharmacology (2847) 2847
body weight (2828) 2828
oncology (2820) 2820
prevention (2785) 2785
spectroscopy (2763) 2763
diet (2701) 2701
public, environmental & occupational health (2701) 2701
lc-ms/ms (2587) 2587
food science & technology (2578) 2578
drug therapy (2563) 2563
analytical chemistry (2557) 2557
prospective studies (2544) 2544
insulin (2520) 2520
glucose (2517) 2517
mass screening (2504) 2504
abridged index medicus (2490) 2490
performance liquid-chromatography (2476) 2476
hypertension (2436) 2436
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (40) 40
Gerstein Science - Stacks (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (24) 24
Online Resources - Online (15) 15
UofT at Mississauga - Stacks (13) 13
UofT at Scarborough - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
UTL at Downsview - May be requested (6) 6
Criminology - Stacks (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
Law (Bora Laskin) - Stacks (4) 4
Media Commons - Microtexts (3) 3
New College (Ivey) - Stacks (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Indust. Rel's & Hum. Resources (Newman) - Library use only (2) 2
OISE - May be requested in 6-10 wks (2) 2
OISE - Theses (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Trinity College (John W Graham) - Reference (2) 2
Collection Dvlpm't (Acquisitions) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Innis College - Stacks (1) 1
Law (Bora Laskin) - Theses (1) 1
OISE - Stacks (1) 1
Robarts - Gov Pub Storage: Request at Reference Desk 4th floor (1) 1
St. Michael's College (John M. Kelly) - On order (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (84718) 84718
Japanese (270) 270
Chinese (236) 236
German (175) 175
French (165) 165
Russian (89) 89
Spanish (60) 60
Polish (44) 44
Portuguese (38) 38
Hungarian (33) 33
Italian (21) 21
Dutch (11) 11
Swedish (11) 11
Turkish (9) 9
Korean (8) 8
Danish (7) 7
Indonesian (5) 5
Norwegian (5) 5
Bulgarian (4) 4
Ukrainian (4) 4
Czech (3) 3
Romanian (3) 3
Arabic (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, ISBN 9781557989369, xv, 272
Book
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2016, Volume 67, Issue 19, pp. 2224 - 2234
.... Objectives The aim of this study was to develop and validate separate models to predict risks for out-of-hospital thrombotic and bleeding events after percutaneous coronary intervention with drug-eluting stents... 
risk | bleeding | thrombosis | PCI | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | VALIDATION | OUTCOMES | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | STRATIFICATION | DURATION | ATRIAL-FIBRILLATION | PREDICTION | United States - epidemiology | Age Factors | Coronary Thrombosis - epidemiology | Anemia - epidemiology | Humans | Middle Aged | Male | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Registries | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Body Mass Index | Drug-Eluting Stents | Acute Coronary Syndrome - epidemiology | Hemorrhage - epidemiology | Risk Assessment | Ticlopidine - analogs & derivatives | Medication Adherence | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Cohort Studies | Thrombosis | Blood clot | Risk factors | Stent (Surgery) | Myocardial infarction | Intervention | Therapy | Surgical implants | Renal function | Angioplasty | Risk | Drug delivery | Bleeding | Body mass index | Ischemia | Blood platelets | Implants | Mathematical models | Thromboembolism | Stents | Aspirin | Decision making | Anemia | Calibration | Patients | Body mass | Body size | Coronary vessels | Clopidogrel | Infarction | Acute coronary syndromes | Platelets
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2016, Volume 78, Issue 1, pp. 41 - 49
...Cancer Chemother Pharmacol (2016) 78:41–49 DOI 10.1007/s00280-016-3020-z ORIGINAL ARTICLE A clinical drug–drug interaction study to evaluate the effect... 
Medicine & Public Health | CYP inhibitors | Clinical pharmacology | Oncology | Cancer Research | Pharmacology/Toxicology | Clinical drug–drug interaction | Pharmacokinetic | Proton-pump inhibitor | P-glycoprotein inhibitor | SINGLE | HUMAN PLASMA | ORAL ABSORPTION | MASS-SPECTROMETRY | GDC-0449 | ONCOLOGY | Clinical drug-drug interaction | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS | HEDGEHOG SIGNALING PATHWAY | SOLID-PHASE EXTRACTION | Fluconazole - pharmacology | Proton Pump Inhibitors - pharmacology | Cytochrome P-450 CYP3A Inhibitors - administration & dosage | Pyridines - administration & dosage | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Area Under Curve | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Fluconazole - administration & dosage | Solubility | Pyridines - pharmacokinetics | Anilides - pharmacokinetics | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Itraconazole - pharmacology | Cytochrome P-450 CYP2C9 Inhibitors - administration & dosage | Cytochrome P-450 CYP2C9 Inhibitors - pharmacology | Drug Interactions | Anilides - administration & dosage | Proton Pump Inhibitors - administration & dosage | Rabeprazole - pharmacology | Female | Itraconazole - administration & dosage | Hydrogen-Ion Concentration | Rabeprazole - administration & dosage | Drug interactions | Cytochrome P-450 | Original
Journal Article
PLOS MEDICINE, ISSN 1549-1277, 06/2019, Volume 16, Issue 6, p. e1002839
Journal Article
by Landier, Jordi and Parker, Daniel M and Thu, Aung Myint and Lwin, Khin Maung and Delmas, Gilles and Nosten, François H and Andolina, Chiara and Aguas, Ricardo and Ang, Saw Moe and Aung, Ei Phyo and Baw, Naw Baw and Be, Saw Aye and B'Let, Saw and Bluh, Hay and Bonnington, Craig A and Chaumeau, Victor and Chirakiratinant, Miasa and Cho, Win Cho and Christensen, Peter and Corbel, Vincent and Day, Nicholas PJ and Dah, Saw Hsa and Delmas, Gilles and Dhorda, Mehul and Dondorp, Arjen M and Gaudart, Jean and Gornsawun, Gornpan and Haohankhunnatham, Warat and Hla, Saw Kyaw and Hsel, Saw Nay and Htoo, Gay Nay and Htoo, Saw Nay and Imwong, Mallika and John, Saw and Kajeechiwa, Ladda and Kereecharoen, Lily and Kittiphanakun, Praphan and Kittitawee, Keerati and Konghahong, Kamonchanok and Khin, Saw Diamond and Kyaw, Saw Win and Landier, Jordi and Ling, Clare and Lwin, Khin Maung and Lwin, Khine Shwe War and Ma, Naw K' Yin and Marie, Alexandra and Maung, Cynthia and Marta, Ed and Minh, Myo Chit and Miotto, Olivo and Moo, Paw Khu and Moo, Ku Ler and Moo, Merry and Na, Naw Na and Nay, Mar and Nosten, François H and Nosten, Suphak and Nyo, Slight Naw and Oh, Eh Kalu Shwe and Oo, Phu Thit and Oo, Tun Pyit and Parker, Daniel M and Paw, Eh Shee and Phumiya, Choochai and Phyo, Aung Pyae and Pilaseng, Kasiha and Proux, Stéphane and Rakthinthong, Santisuk and Ritwongsakul, Wannee and Salathibuphha, Kloloi and Santirad, Armon and Sawasdichai, Sunisa and von Seidlein, Lorenz and Shee, Paw Wah and Shee, Paw Bway and Tangseefa, Decha and Thu, Aung Myint and Thwin, May Myo and Tun, Saw Win and Wanachaloemlep, Chode and White, Lisa J and White, Nicholas J and Wiladphaingern, Jacher and Win, Saw Nyunt and Yee, Nan Lin and Yuwapan, Daraporn and Malaria Elimination Task Force Group and Malaria Elimination Task Force Grp
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
.... A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested that mass drug administration was safe, and when added to provision of early diagnosis and treatment... 
RESISTANCE | MEDICINE, GENERAL & INTERNAL | AREA | SPREAD | EPIDEMIOLOGY | Prevalence | State Medicine | Artemether, Lumefantrine Drug Combination | Humans | Fluorenes - therapeutic use | Male | Ethanolamines - administration & dosage | Primaquine - administration & dosage | Incidence | Rural Population | Malaria, Falciparum - diagnosis | Malaria, Falciparum - epidemiology | Female | Fluorenes - administration & dosage | Drug Resistance | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Mass Drug Administration - methods | Primaquine - therapeutic use | Myanmar - epidemiology | Ethanolamines - therapeutic use | Early Diagnosis | Drug Combinations | Plasmodium falciparum | Diagnosis | Malaria | Analysis | Intervention | Dihydroartemisinin | Vector-borne diseases | Medical research | Primaquine | Hot spots | Artemisinin | Parasites | Dosage | Medical diagnosis | Molecular chains | Surveys | Charities | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Villages | Artemether | Histocompatibility antigen HLA | Adults | Diagnostic systems | Genotypes | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
Analytical and Bioanalytical Chemistry, ISSN 1618-2642, 4/2018, Volume 410, Issue 11, pp. 2815 - 2828
Generation of skin distribution profiles and reliable determination of drug molecule concentration in the target region are crucial during the development process of topical products for treatment... 
Biochemistry, general | Skin penetration | Food Science | Quantification | Drug distribution | Mass spectrometry imaging | Human skin | Laboratory Medicine | MALDI-MSI | Chemistry | Analytical Chemistry | Monitoring/Environmental Analysis | Characterization and Evaluation of Materials | CHEMISTRY, ANALYTICAL | HUMAN STRATUM-CORNEUM | BIOCHEMICAL RESEARCH METHODS | PENETRATION | MOLECULAR-SIZE | MICROSCOPY | MASS-SPECTROMETRY | TISSUE-SECTIONS | ATOPIC-DERMATITIS | PERCUTANEOUS-ABSORPTION | PSORIASIS | Pyrroles - pharmacokinetics | Benzamides - pharmacokinetics | Skin - metabolism | Humans | Aminopyridines - pharmacokinetics | Pyridines - pharmacokinetics | Drug Discovery - methods | Benzamides - administration & dosage | Cyclopropanes - administration & dosage | Phosphodiesterase 4 Inhibitors - administration & dosage | Pyrroles - administration & dosage | Piperidines - pharmacokinetics | Pyrazoles - pharmacokinetics | Cyclopropanes - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Aminopyridines - administration & dosage | Piperidines - administration & dosage | Pyridines - administration & dosage | Acetamides - pharmacokinetics | Phosphodiesterase 4 Inhibitors - pharmacokinetics | Pyrimidines - administration & dosage | Skin Absorption | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Pyrimidines - pharmacokinetics | Administration, Topical | Acetamides - administration & dosage | Pharmaceutical research | Topical medication | Pharmaceutical industry | Innovations | Testing | Formulations | Explants | Psoriasis | Medical treatment | Spatial discrimination | Imaging techniques | Ions | Mass spectroscopy | Desorption | Drug development | Tissues | Dermatitis | Ionization | Lasers | Atopic dermatitis | Imaging | Skin diseases | Skin | Mass spectrometry | Spatial resolution | Physicochemical properties
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2009, Volume 68, Issue 6, pp. 928 - 935
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Numerous cocktails using concurrent administration of several cytochrome P450 (CYP... 
in vivo drug-drug interaction | cocktail | CYP | in vivo drug–drug interaction | Cocktail | In vivo drug-drug interaction | DRUG | CAFFEINE | COMBINED PHENOTYPIC ASSESSMENT | METOPROLOL | OMEPRAZOLE TREATMENT | XANTHINE-OXIDASE | METABOLISM | ENZYMES | IN-VIVO | N-ACETYLTRANSFERASE-2 | PHARMACOLOGY & PHARMACY | Anti-Anxiety Agents - administration & dosage | Caffeine - administration & dosage | Anticoagulants - administration & dosage | Area Under Curve | Humans | Midazolam - administration & dosage | Cytochrome P-450 CYP1A2 - administration & dosage | Male | Metabolic Clearance Rate | Warfarin - administration & dosage | Caffeine - pharmacokinetics | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Drug Interactions | Adult | Drug Therapy, Combination | Administration, Oral | Omeprazole - administration & dosage | Omeprazole - pharmacokinetics | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Central Nervous System Stimulants - pharmacokinetics | Anticoagulants - pharmacokinetics | Central Nervous System Stimulants - administration & dosage | Drug Combinations | Cytochrome P-450 CYP1A2 - pharmacokinetics | Omeprazole | Warfarin | Analysis | Drug interactions | Cytochrome P-450 | Physiological aspects | Liquid chromatography | Mass spectrometry | Caffeine | Drug Metabolism
Journal Article